Wednesday, 2nd May 2012
China's Pharmaceutical Distribution: Poised for Change
Source: A.T. Kearney
From the report:
An aging population, increasing disposable income, and growing awareness of health needs helped propel China's pharmaceutical industry to 20 percent yearly growth in the past five years and $110 billion in revenues in 2011. This strong growth is expected to continue...By 2013, China could overtake Japan to become the world's second largest pharmaceutical industry, behind the United States.
However, the distribution of drugs remains a challenge, with a landscape of multiple channels, decision makers, and regulations adding significant complexity to the market. How can pharmaceutical firms overcome these challenges to generate immediate results and a long-term advantage?
+ Link to full report (PDF; 1.35 MB) or HTML
By Peggy Garvin
Peggy Garvin, of Garvin Information Consulting, is the author of United States Government Internet Directory (Bernan Press) and Real World Research Skills, 2009 (TheCapitol.Net). In her 20 years in the information business, Peggy has managed electronic information products and services in a variety of environments, including commercial publishing, e-commerce, law firms, and the Congressional Research Service of the Library of Congress. Peggy's work has been recognized with the 2011 SLA Dow Jones Leadership Award. She has a Masters of Library Science degree from Syracuse University School of Information Studies.
More articles by Peggy Garvin »
Please note: DocuTicker's editors collect citations for full-text PDF reports freely available on the web but we do not archive these reports. When you click a link to find and/or download the report, you are leaving the DocuTicker site. DocuTicker makes no representations regarding the ongoing availability of any report or any external resource. Links were accurate as of the date of posting.